Experimentar demo Abra uma conta
Trading
CFD
Binárias
Criptomoedas
Banking
B2B
Info de Mercado
Sobre nós
Experimentar demo Abra uma conta

Indivior to sell treatment rights to China's Zhejiang

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The drugmaker Indivior stated on Monday it was selling the rights tied with its Chinese opioid addiction treatment Sai Bo Song to the privately-owned Zhejiang Pukang Biotechnology for about $122.5M.
Back to articles

Actual Topics

04 Feb 2019

Julius Baer to trim jobs amid poor profitability

Julius Baer is planning to trim up to 140 jobs, which is 2% of its workforce, on the back of the company's plan to cut costs announced this Monday, following a tough end of 2018.

04 Feb 2019

Euronext likely to sweeten bid for Oslo Bors

On Monday, Euronext, the pan-EU stock market operator, stated it might sweeten its bid for Oslo Bors, as Nasdaq had made a rival proposal.

04 Feb 2019

Taptica confirms merger with RhythmOne

Taptica International, the video advertising company, confirmed on Monday it would combine with its competitor RhythmOne in an all-share merger deal, which now was awaiting shareholders' approval.